Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00937118 · ClinicalTrials.gov registry record

Damage Control for Duodenal and Combined Duodenal-Pancreatic Injuries

A clinical trial, sponsored by Oregon Health and Science University.

Completed
Registry status
43
Enrollment target

NCT00937118: Completed study, sponsored by Oregon Health and Science University.

NCT00937118 is a clinical trial that has completed, run by Oregon Health and Science University. The registered enrollment target is 43 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00937118 has completed, sponsored by Oregon Health and Science University.

COMPLETED
Registry status
43 participants
Enrollment target

Study Summary

The management of significant duodenal injuries and combined duodenal-pancreatic injuries continues to be challenging and controversial, and several techniques have been advocated over the years. One technique surgeons employ is the damage control/planned reoperation strategy. At the trauma center, the advent of damage control and other planned re-operation strategies has resulted in an evolution in the investigators management of duodenal lacerations and combined duodenal-pancreatic injuries. In this retrospective review, the investigators intend to quantify the investigators change in practice and to report its outcome compared to previous practice. Using the OHSU Trauma Laparotomy Outcomes Database, the investigators will identify all patients receiving trauma laparotomy for a duodenal or duodenal/pancreatic injury for a period of 20 years, from 1989-2009. A number of data points will be retrieved from patients' medical records, including but not limited to grade of duodenal injury, mechanism of injury, Injury Severity Score, and others.

Primary Outcome

Duodenal-related complications including leak, obstruction, and abscess

Trial Details

FieldValue
Enrollment Target 43 participants
Start Date 2009-07
Est. Completion 2010-11

What the finished NCT00937118 record still lists

NCT00937118 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 43 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT00937118 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00937118 about?

NCT00937118 is a clinical study titled "Damage Control for Duodenal and Combined Duodenal-Pancreatic Injuries". The management of significant duodenal injuries and combined duodenal-pancreatic injuries continues to be challenging and controversial, and several techniques have been advocated over the years. One technique surgeons employ is the damage control/planned reoperation strategy. At the trauma center, ...

What is the current status of trial NCT00937118?

This trial is currently completed. The enrollment target is 43 participants. The study started on 2009-07. Estimated completion is 2010-11.

Who is sponsoring clinical trial NCT00937118?

This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03726359 · 43 participants · Phase 1

    Phase I Study of Fractionated Stereotactic Radiation Therapy

  • NCT03850418 · 43 participants · Phase 2

    Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant

  • NCT04144023 · 43 participants · Phase 1

    A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ

  • NCT04176718 · 43 participants · Phase 2

    Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00937118, the US trial registry maintained by the National Library of Medicine. NCT00937118 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.